Product

MUCOSOLVAN tablets 30 mg contain an expectorant which is used to thin the mucus in acute and chronic bronchial and lung diseases where thick, tenacious mucus is a problem. MUCOSOLVAN tablets 30 mg are used to thin the mucus in acute and chronic bronchial and lung diseases where tenacious mucus is a problem. How to use The recommended dose is: Children from 6 to 12 years of age: The usual dose is ½ a tablet 2 - 3 times daily (equivalent to 2 - 3 x 15 mg ambroxol hydrochloride per day). Adults and adolescents over 12 years of age: The usual dose is 1 tablet 3 times daily (equivalent to 3 x 30 mg ambroxol hydrochloride per day) for the first 2 - 3 days and 1 tablet twice daily (equivalent to 2 x 30 mg ambroxol hydrochloride per day) thereafter. For adults and adolescents over 12 years of age, the therapeutic effect may be enhanced by increasing the dose to 2 tablets twice daily (equivalent to 120 mg ambroxol hydrochloride per day). Method and duration of administration MUCOSOVAN tablets 30 mg are for oral use. MUCOSOLVAN tablets 30 mg can be taken with or without food and should be swallowed whole with plenty of liquid (e.g. water, tea or fruit juice). Warnings and precautions Talk to your doctor or pharmacist before taking this medicine. There have been reports of severe skin reactions associated with the administration of ambroxol hydrochloride. If you develop a skin rash (including lesions of the mucous membranes such as mouth, throat, nose, eyes, genitals), stop using MUCOSOLVAN tablets 30 mg and contact your doctor immediately. Side Effects If you experience any of the following symptoms you should contact your doctor or go to the hospital straight away: Immune system disorders Rare: Hypersensitivity reactions Not known: Hypersensitivity reactions include anaphylactic shock, angioedema (rapid swelling of the skin, subcutaneous tissue, mucous membranes or submucosal tissues) and pruritus Skin and subcutaneous tissue disorders Rare: Rash, urticaria Not known: Severe skin reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis syndrome, and acute generalized pustular rash) Gastrointestinal disorders Common: Nausea Uncommon: Vomiting, diarrhoea, dyspepsia, abdominal pain Very rare: Salivation Respiratory, thoracic and mediastinal disorders Not known: Dyspnoea (e.g. symptoms of hypersensitivity reactions) General disorders and administration site conditions Uncommon: Fever, mucosal reactions Storage Information Store below 30ºC Drug Interactions Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines. Ambroxol and cough suppressants Simultaneous use of MUCOSOLVAN tablets 30 mg and cough suppressants may lead to the develop- ment of a dangerous accumulation of secretions owing to reduction of the cough reflex and should be undertaken only after careful risk-benefit assessment. Ingredients The active substance is ambroxol hydrochloride. The other ingredients are: Colloidal anhydrous silica, lactose monohydrate, maize starch, magnesium stearate Specifications MUCOSOLVAN tablets 30 mg are round, white, scored tablets marked "67 C". The other face is impressed with the company symbol.
We are Sorry, this product is unavailable now, explore other products.